We often hear in the news about the discovery of new ground breaking medicines. These medicines help save lives and progress the treatment of conditions such as Heptitis, Malaria, HIV, MS and many, many others. These illnesses can touch family members, friends and people all over the world. Mark’s passion is in creating a research environment, underpinned by world class science and engineering, to help in the development and launch of these new medicines.
Mark holds the position of Chief Executive Officer and Director in APC, a pharmaceutical and biotech process R&D Company that was founded in 2011. Within this position Mark leads APC’s research and technology roadmap, corporate financing strategy, global expansion and ultimately is accountable for the delivery of APC’s mission to accelerate the development and launch of new and existing therapies. Mark has a BE and PhD in Chemical Engineering and is also an Adjunct Professor to the UCD Chemical Engineering School.